Furthermore, the information about alteration of IFN gene helps to expand the clinical application of interferon α/β therapy in the type of cancers showing higher mortality associated with CNA of the IFN gene cluster e.g., breast, and uterine cancers. Here, IFNA1 is linked to uterine cancer.